MedPath

EMORY UNIVERSITY

EMORY UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1836-12-10
Employees
10K
Market Cap
-
Website
http://www.emory.edu

Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study

Phase 2
Completed
Conditions
Hypertension
Interventions
Drug: Melatonin
Drug: Placebo
First Posted Date
2010-05-03
Last Posted Date
2016-02-26
Lead Sponsor
Emory University
Target Recruit Count
40
Registration Number
NCT01114373
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Diabetes in the Elderly: Retrospective Study

Completed
Conditions
Diabetes
First Posted Date
2010-04-15
Last Posted Date
2013-11-14
Lead Sponsor
Emory University
Target Recruit Count
1409
Registration Number
NCT01104168
Locations
🇺🇸

Bud Terrace Homes, Atlanta, Georgia, United States

🇺🇸

A.G. Rhodes Homes, Atlanta, Georgia, United States

Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection

Phase 2
Completed
Conditions
Myeloma
Lymphoma
Interventions
First Posted Date
2010-03-30
Last Posted Date
2014-09-29
Lead Sponsor
Emory University
Target Recruit Count
45
Registration Number
NCT01095757
Locations
🇺🇸

Emory University Winship Cancer Institute, Atlanta, Georgia, United States

A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians

Not Applicable
Completed
Conditions
Diabetes
Obesity
Interventions
Behavioral: Lifestyle Intervention Classes
First Posted Date
2010-03-11
Last Posted Date
2013-09-25
Lead Sponsor
Emory University
Target Recruit Count
16
Registration Number
NCT01084928
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Stimulus Intensity in Left Ventricular Leads

Not Applicable
Completed
Conditions
Congestive Heart Failure
Interventions
Other: LV stimulus intensity
First Posted Date
2010-02-02
Last Posted Date
2013-12-17
Lead Sponsor
Emory University
Target Recruit Count
60
Registration Number
NCT01060449
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

Pilot Study Assessing Oxidative Stress in Children

Completed
Conditions
Adrenal Insufficiency
Critical Illness
First Posted Date
2010-01-20
Last Posted Date
2015-06-04
Lead Sponsor
Emory University
Target Recruit Count
102
Registration Number
NCT01052207
Locations
🇺🇸

Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States

Glutamine Supplementation in Cystic Fibrosis

Phase 2
Completed
Conditions
Cystic Fibrosis
Immune Function
Interventions
Dietary Supplement: Glutamine
Dietary Supplement: L-alanine
First Posted Date
2010-01-20
Last Posted Date
2015-01-14
Lead Sponsor
Emory University
Target Recruit Count
17
Registration Number
NCT01051999
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension

Phase 4
Completed
Conditions
High Blood Pressure
Interventions
First Posted Date
2010-01-14
Last Posted Date
2017-04-11
Lead Sponsor
Emory University
Target Recruit Count
91
Registration Number
NCT01049009
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease

Phase 2
Completed
Conditions
Peripheral Arterial Disease
Interventions
Drug: Granulocyte-Macrophage Stimulating Factor (GM-CSF)
Drug: Placebo
First Posted Date
2009-12-31
Last Posted Date
2014-12-23
Lead Sponsor
Emory University
Target Recruit Count
159
Registration Number
NCT01041417
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor Cells

Phase 4
Completed
Conditions
Hypertension
Interventions
First Posted Date
2009-12-31
Last Posted Date
2014-12-19
Lead Sponsor
Emory University
Target Recruit Count
96
Registration Number
NCT01041287
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath